Table 4.
Projects | Quantity | Break Point | MIC50 | MIC90 | MIC Range |
---|---|---|---|---|---|
Tigecycline | 962 | S≤0.03 R≥0.25 | 0.5 | 2 | 0.02–64 |
Compound sulfamethoxazole | 4978 | S≤2 R≥4 | 4 | 16 | 0.25–128 |
Ciprofloxacin | 5430 | S≤1 R≥4a | 4 | 8 | 0.01–64 |
Etapenan | 724 | S≤0.5 R≥2 | 8 | 16 | 0.25–64 |
Levofloxacin | 5646 | S≤2 R≥8 | 8 | 16 | 0.06–64 |
Tobramycin | 3546 | S≤4 R≥16 | 16 | 16 | 0.5–32 |
Meropenem | 5359 | S≤1 R≥4 | 16 | 32 | 0.06–128 |
Gentamicin | 5370 | S≤4 R≥16 | 16 | 16 | 0.5–32 |
Amikacin | 5479 | S≤16 R≥64 | 16 | 64 | 1–128 |
Imipenem | 5658 | S≤1 R≥4 | 16 | 32 | 0.12–64 |
Amoxicillin/clavulanic acid | 1027 | S≤8 R≥32 | 32 | 32 | 0.5–64 |
Cefoxitin | 2218 | S≤8 R≥32 | 32 | 64 | 1–128 |
Cefepime | 5694 | S≤2 R≥16 | 32 | 64 | 0.12–128 |
Cefotaxime | 1327 | S≤1 R≥4 | 64 | 64 | 0.12–128 |
Aztreonam | 3738 | S≤4 R≥16 | 64 | 128 | 0.25–128 |
Cefuroxime | 4528 | S≤8 R≥32 | 64 | 128 | 1–128 |
Ceftriaxone | 4624 | S≤1 R≥4 | 64 | 128 | 0.12–128 |
Cefazolin | 5074 | S≤16 R≥32 | 64 | 128 | 1–128 |
Ceftazidime | 5364 | S≤4 R≥16 | 64 | 64 | 0.06–128 |
Piperacillin | 3414 | S≤16 R≥128 | 128 | 256 | 2–256 |
Piperacillin/tazobactam | 5643 | S≤16 R≥128 | 128 | 256 | 0.5–256 |
Note: MIC50/MIC90, MIC50 and MIC90 can inhibit 50% or 90% of the tested bacteria.
Abbreviation: MIC, minimum inhibitory concentration.